EASL would like to thank everyone who attended for making the Prague Special Conference on Therapy of Hepatitis C: Clinical Application and Drug Development, an enormous success.
This was a landmark event, being the first Special Conference on the topic of HCV co-organised by both EASL and the AASLD; the result was outstanding attendance, and a strengthened bond between the two associations.
EASL has prepared this Conference Highlights report featuring key topics discussed and presented during the Special Conference in Prague. This report will enable you to keep up to date with the latest happenings in the field.
New study evaluates efficacy of PET imaging to manage chronic liver diseases
EASL governing board announces new Vice-Secretary
A web-based program is as effective as group counseling for patients with non-alcoholic fatty liver disease